QuidelOrtho reports Q2 adjusted EPS 12c, consensus 1c

Reports Q2 revenue $614M, consensus $611.88M. “Our second quarter results demonstrate our continuing commitment to commercial and operational execution,” said Brian J. Blaser, President and Chief Executive Officer, QuidelOrtho (QDEL). “Our team delivered solid top and bottom-line results while also navigating a challenging global environment. We achieved several of our key priorities during the second quarter, including realizing our previously announced $100 million in annualized cost-savings; announcing our intention to acquire LEX Diagnostics; and initiating a major manufacturing site consolidation. Based on our year-to-date results, we believe we are well positioned to deliver sustainable value over time for our shareholders, customers, and employees.”